** Shares of Immuron IMC.AX rise as much as 36% to
A$0.170, their highest since Oct. 8, 2021
** IMC rose 89.4% in previous session; on track for its
biggest weekly gain since late July 2020
** Drug developer on Thursday reported positive results from
the clinical trials for its flagship diarhhea drug, Travelan
** About 12.2 mln shares change hands on Friday, compared
with the 30-day average volume of 1.3 mln
** Stock up 62.3% YTD, based on last close
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))